Clik here to view.
Pharma CEOs Confident About Growth And Opportunity In Next 12 Months
According to PriceWaterHouseCoopers’ 12th annual CEO survey, one third of pharmaceutical CEOs are very confident they can increase their revenues in the next 12 months. A total of 47 CEOs were queried...
View ArticleBig Pharma Looking For M&A To Fill Their Drug Pipeline
Crisis brings change. It is during times like these, of general economic duress, that one can see this in motion and experience its consequences. Pharmaceutical companies are experiencing perhaps the...
View ArticleRisk analysis and Quality Systems in Development of LEAN Compliance Systems...
In an era of increased performance demands both by government bodies and the public in general, pharmaceutical companies must depend more than ever on sound quality control. Two concepts that merge in...
View ArticleLean Operational Compliance in the New Pharmaceutical Industry Environment
The era of end-process testing seems to be over. The adoption by the pharmaceutical industry of new practices and methodologies aimed at increasing their efficiency and flexibility has made it possible...
View ArticleClik here to view.
Lean Analysis and Optimization for Pharmaceutical and Biopharmaceutical...
With the drug industry facing a drought of new drugs in the pipeline, lower revenues, lower margins and increased oversight, the times when the opposite situation made manufacturing efficiency and...
View ArticleLean Manufacturing for the Competitive Edge
Factors within the pharmaceutical industry have combined with economy-related issues to force pharmaceutical companies to seek new ways of maintaining or regaining their competitive edge. Increasing...
View ArticleLean Manufacturing and PAT – The Next Level For Pharma
In 2003 the FDA announced the Process Analytical Technology (PAT) initiative to “encourage the voluntary development and implementation of innovative pharmaceutical manufacturing and quality...
View ArticlePharmaceutical Consultants-The Key to a Rapidly Changing Industry
When market conditions, and methods of manufacturing, testing, and technology remain virtually unchanged for long periods, companies within that industry generally manage quite well doing everything...
View ArticleBARDA and their Countermeasures Initiative
Last month was the PHEMCE conference in Washington DC which translated the governments approach to countermeasures production for the next decade or so. From the discussions it appears that BARDA will...
View ArticleIssues for Device Combination Products
The development of medical device combination products convenience packages continues to present interesting technical and regulatory issues. Inclusion of pre-sterilized syringes and applicators as...
View ArticleWhat is Pharmaceutical Outsourcing?
Many arguments have been made both for and against pharmaceutical outsourcing in the pursuit of achieving some sort of competitive advantage. By allowing outside firms to concentrate on specific...
View ArticleThe Exciting and Future Role Of Stem Cells in the Health Industry
… to reprogram adult stem cells the treatment of serious diseases such as cancer, and even curing blindness, are now thought to be within reach. Even pharmaceutical firms and pharmaceutical...
View ArticleAAI, CONSUMER GROUPS ENCOURAGE CONGRESS TO BAN PATENT SETTLEMENTS AND RESTORE...
… payments in pharmaceutical patent settlements in the final health reform legislation that both the House and Senate will consider soon. During the past decade, some branded and generic pharmaceutical...
View ArticleGuilty as Charged: The Premature Stop of Clinical Trials Exaggerates the...
… earlier, since it would reach the market faster. Dr. Montori explained that almost everyone doctors, researchers, investors, pharmaceutical firms, scientific journals, and even reporters benefits...
View Article
